The global bio-decontamination market is experiencing significant growth, driven by increasing awareness of infection control, stringent regulatory standards, and technological advancements. Bio-decontamination involves eliminating harmful microorganisms using chemical and physical methods, ensuring sterile environments in healthcare and pharmaceutical settings.

The global bio-decontamination market size was valued at USD 211.9 million in 2024 and is projected to grow to USD 219.9 million in 2025, reaching USD 297.7 million by 2032. This represents a compound annual growth rate (CAGR) of 4.4% during the forecast period.

Top Companies in the Market

• STERIS (U.S.)
• Bioquell (Ecolab) (U.K.)
• JCE Biotechnology (France)
• Fedegari Autoclavi S.p.A. (Italy)
• TOMI Environmental Solutions, Inc. (U.S.)
• Amira Srl Unipersonale (Italy)
• Zhejiang Tailin Bioengineering Co., Ltd. (China)
• Noxilizer, Inc. (U.S.)
• ClorDisys Solutions Inc. (U.S.)

Key Industry Development

In August 2023, TOMI Environmental Solutions, Inc. collaborated with Cellares to integrate its ionized Hydrogen Peroxide (iHP) technology, SteraMist, into a new cell therapy manufacturing solution, the Cell Shuttle produced by Cellares.

Market Drivers & Restraints

Drivers:

• Rising prevalence of hospital-acquired infections (HAIs) necessitating stringent sterilization protocols.
• Increasing demand for sterile pharmaceutical and medical device manufacturing environments.